|
RAB8B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.68500000011329E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.2123000005011E-07 |
| Normal-vs-Stage2 |
1.652150E-02 |
| Normal-vs-Stage3 |
1.46989999949554E-07 |
| Normal-vs-Stage4 |
1.93379999791077E-08 |
| Stage1-vs-Stage2 |
2.242600E-01 |
| Stage1-vs-Stage3 |
8.342400E-01 |
| Stage1-vs-Stage4 |
3.713900E-02 |
| Stage2-vs-Stage3 |
2.127400E-01 |
| Stage2-vs-Stage4 |
2.533700E-02 |
| Stage3-vs-Stage4 |
9.689700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.23970000049023E-07 |
| Normal-vs-AfricanAmerican |
3.02909919369654E-11 |
| Normal-vs-Asian |
4.70619999970445E-07 |
| Caucasian-vs-AfricanAmerican |
5.78639999999631E-05 |
| Caucasian-vs-Asian |
4.728000E-01 |
| AfricanAmerican-vs-Asian |
1.309550E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72080000249153E-08 |
| Normal-vs-Female |
7.7678999998998E-07 |
| Male-vs-Female |
3.034400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.35190000042307E-07 |
| Normal-vs-Age(41-60Yrs) |
6.70049999929034E-08 |
| Normal-vs-Age(61-80Yrs) |
2.249600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.413710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.856200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.237000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.980000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.220100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.020600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.632200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.989000E-01 |
| Classical-VS-Follicular |
4.238100E-03 |
| Classical-VS-Other |
2.608800E-01 |
| Classical-VS-Normal |
4.36970000183834E-08 |
| Tall-VS-Follicular |
3.322500E-03 |
| Tall-VS-Other |
5.809400E-01 |
| Tall-VS-Normal |
2.14940000020647E-07 |
| Follicular-VS-Other |
8.975800E-03 |
| Follicular-VS-Normal |
2.581900E-02 |
| Other-VS-Normal |
2.618800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.5857000000018E-06 |
| Normal-vs-N1 |
6.81209977315689E-10 |
| N0-vs-N1 |
3.808000E-04 |
|
|
